![]() Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country - Analysis and Forecast, 2024-2033
Introduction to Europe Hereditary Genetic Testing Market The Europe hereditary genetic testing market was valued at $7.13 billion in 2024 and is anticipated to reach $21.06 billion by 2034, witn... もっと見る
SummaryIntroduction to Europe Hereditary Genetic Testing MarketThe Europe hereditary genetic testing market was valued at $7.13 billion in 2024 and is anticipated to reach $21.06 billion by 2034, witnessing a CAGR of 12.79% during the forecast period 2024-2034. The market in Europe is expanding rapidly due to continuous technological improvements. Genetic testing is now more accurate, efficient, and affordable thanks to advancements in genetic sequencing technologies, especially next-generation sequencing (NGS). Demand is being driven by growing awareness of the advantages of genetic testing for diagnosing and treating hereditary conditions among healthcare professionals and the public. Additionally, the need for early diagnosis and individualized treatment solutions is highlighted by the rising incidence of genetic disorders and hereditary cancers. The expanding applications of genetic testing, such as prenatal and newborn screening, oncology, and precision medicine, further bolster the market's growth. The quality and dependability of genetic tests are guaranteed by regulatory support and harmonized European guidelines, which promote market expansion throughout the region. Market Introduction The market for hereditary genetic testing in Europe is growing quickly due to developments in genetic sequencing technologies, rising awareness, and a growing need for individualized medical care. In order to diagnose inherited disorders, detect genetic disease predispositions, and facilitate early interventions for conditions like rare genetic disorders, cystic fibrosis, and hereditary cancers, hereditary genetic testing is essential. The accuracy, effectiveness, and affordability of genetic tests have increased dramatically with the widespread use of next-generation sequencing (NGS) technologies, opening up access to them for patients and healthcare professionals alike. Further propelling market expansion are government initiatives supporting newborn screening and carrier testing programs, as well as advantageous regulatory frameworks and reimbursement policies. The rising incidence of genetic disorders and hereditary cancers is driving demand for comprehensive testing solutions. Additionally growing in popularity are direct-to-consumer (DTC) genetic testing services, which give people access to genetic information without a doctor's prescription. The market's scope is being further expanded by significant investments in reproductive health testing, oncology genetics, and personalized medicine. The market for hereditary genetic testing is expected to grow steadily as long as Europe prioritizes precision medicine and early disease detection. This growth will be aided by technological advancements, harmonized regulations, and rising public awareness. Market Segmentation: Segmentation 1: by Genetic Testing Type • Oncology Genetic Testing • Cardiology Genetic Testing • Neurology Genetic Testing • Newborn Screening • Prenatal Screening (NIPT) and Preimplantation Testing • Rare Disease Testing • Direct-to-consumer (DTC) Testing Segmentation 2: by Region • Europe o Germany o U.K. o France o Spain o Netherlands o Rest-of-Europe How can this report add value to an organization? Product/Innovation Strategy: The Europe hereditary genetic testing market has been extensively segmented based on various categories, such as genetic testing type and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years. Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments. Competitive Strategy: The Europe hereditary genetic testing market has numerous established players with product portfolios. Key players in the Europe hereditary genetic testing market analyzed and profiled in the study involve established players offering products for hereditary genetic testing. Key Market Players and Competition Synopsis The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. Some prominent names established in this market are: • Centogene AG • Eurofins Scientific SE • F. Hoffmann-La Roche Ltd Table of ContentsExecutive SummaryScope and Definition 1 Hereditary Genetic Testing: Industry Outlook 1.1 Current State of Hereditary Genetic Testing 1.2 Market Footprint and Future Potential 1.3 Trends: Current and Future Impact Assessment 1.3.1 Increasing Demand for Direct-to-consumer Testing 1.3.2 Increasing Launch of Innovative Products and Regulatory Approvals in Genetic Testing Ecosystem 1.4 R&D Review 1.4.1 Patent Filing Trend (by Year, Country) 1.5 Total Addressable Market and Penetration 1.6 Legal and Regulatory Framework 1.6.1 Europe 1.6.1.1 Germany 1.6.1.2 France 1.6.1.3 Italy 1.7 Reimbursement Scenario 1.8 Market Dynamics 1.8.1 Market Drivers 1.8.1.1 Rising Prevalence of Genetic Disorders along with Rare Diseases 1.8.1.2 Increasing Inorganic Growth Activities in the Field of Hereditary Genetic Testing 1.8.1.3 Increasing Number of Hereditary Genetic Tests 1.8.2 Market Restraints 1.8.2.1 High Cost Associated with Testing 1.8.2.2 Shortage of Genetic Counselors 1.8.3 Market Opportunities 1.8.3.1 Expansion into Emerging Markets 2 Region 2.1 Drivers and Restraints 2.2 Europe 2.2.1 Regional Overview 2.2.2 Driving Factors for Market Growth 2.2.3 Factors Challenging the Market 2.2.4 France 2.2.5 Germany 2.2.6 U.K. 2.2.7 Spain 2.2.8 Netherlands 2.2.9 Rest-of-Europe 3 Markets - Competitive Benchmarking & Company Profiles 3.1 Competitive Landscape 3.1.1 Key Strategies and Development 3.1.1.1 Mergers and Acquisitions 3.1.1.2 Product Launches 3.1.1.3 Synergistic Activities 3.1.1.4 Business Expansion Activities and Others 3.1.2 Company Share Analysis 3.2 Company Profiles 3.2.1 Centogene AG 3.2.1.1 Overview 3.2.1.2 Top Products/Product Portfolio 3.2.1.3 Top Competitors 3.2.1.4 Key Personnel 3.2.1.5 Analyst View 3.2.2 Eurofins Scientific SE 3.2.2.1 Overview 3.2.2.2 Top Products 3.2.2.3 Top Competitors 3.2.2.4 Key Personnel 3.2.2.5 Analyst View 3.2.3 F. Hoffmann-La Roche Ltd 3.2.3.1 Top Products 3.2.3.2 Top Competitors 3.2.3.3 Key Personnel 3.2.3.4 Analyst View 4 Research Methodology 4.1 Data Sources 4.1.1 Primary Data Sources 4.1.2 Secondary Data Sources 4.1.3 Data Triangulation 4.2 Market Estimation and Forecast 4.3 Criteria for Company Profiling List of Figures Figure 1: Hereditary Genetic Testing Market, by Region, $Billion, 2023, 2027, and 2033 Figure 2: Europe Hereditary Genetic Testing Market (by Testing Type), $Billion, 2023 and 2033 Figure 3: Key Events to Keep Track of in the Hereditary Genetic Testing Market Figure 4: Types of Hereditary Genetic Tests Figure 5: Hereditary Genetic Testing Market, Patent Analysis (by Year), January 2021-April 2024 Figure 6: Hereditary Genetic Testing Market, Patent Analysis (by Country), January 2021-April 2024 Figure 7: Europe Hereditary Genetic Testing Market Scenario, 2023 Figure 8: Analysis of Market Navigating Factors, 2024-2033 Figure 9: Rising Prevalence of Genetic Disorders Figure 10: Prevalence of a Few Rare Diseases Figure 11: Few Major Inorganic Growth Activities in the Hereditary Genetic Testing Market Figure 12: Number of Hereditary Genetic Tests Registered on Genetic Testing Registry, by Year Figure 13: Need for More Genetic Counselors Figure 14: Key Expansions in the Past Few Years Figure 15: France Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 16: Germany Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 17: U.K. Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 18: Spain Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 19: Netherlands Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 20: Rest-of-Europe Hereditary Genetic Testing Market, $Billion, 2022-2033 Figure 21: Number of Mergers and Acquisitions (by Company), January 2021-April 2024 Figure 22: Number of Product Launches (by Company), January 2021-April 2024 Figure 23: Synergistic Activities Share (by Company), January 2021-April 2024 Figure 24: Business Expansion Activities Share (by Company), January 2021-April 2024 Figure 25: Hereditary Genetic Testing Market, Company Revenue Share Analysis, $Billion, 2023 Figure 26: Data Triangulation Figure 27: Top-Down and Bottom-Up Approach Figure 28: Assumptions and Limitations List of Tables Table 1: Market Snapshot Table 2: Opportunities across Regions Table 3: Hereditary Genetic Testing Market, Product Launches and Regulatory Approvals Table 4: Regulatory Bodies Governing Hereditary Genetic Testing Table 5: Europe Hereditary Genetic Testing Market (by Genetic Testing Type), $Billion, 2022-2033 Press Release
According to a premium market intelligence study by BIS Research, the Europe hereditary genetic testing market is projected to reach $21.06 billion by 2033. The study also highlights that the market is set to witness a CAGR of 12.79% during the forecast period 2024-2033.
The Europe Hereditary Genetic Testing Market: Drivers and Challenges Markets Drivers • The increasing prevalence of genetic disorders and rare diseases in Europe is driving the demand for hereditary genetic testing services. • The growing applications of hereditary genetic tests across various medical specialties, including oncology, neurology, and reproductive health, are contributing to market growth in Europe. Market Challenges • Ethical considerations related to genetic privacy and data protection regulations pose challenges to the adoption and implementation of hereditary genetic testing services in Europe. • The shortage of trained genetic counselors in Europe limits the effective utilization of genetic testing services and patient counselling. USPs of report • Analysis of business drivers and challenges of the Europe Hereditary Genetic Testing Market • Detailed analysis of Hereditary Genetic Testing Market for U.K., France, Netherlands, Spain, and Germany • Market regulations and key trends in the hereditary genetic testing market Analyst’s Perspective According to Swati Sood, Principal Analyst – BIS Research, “The hereditary genetic testing market is poised for robust growth, projected to expand at a significant rate due to technological advancements in genomics and increased awareness of the benefits of early genetic screening. This surge is further supported by the rising prevalence of genetic disorders, driving demand for precise diagnostics and personalized medical approaches.” Key Questions Answered in the Report • What are the major market drivers, challenges, and opportunities in hereditary genetic testing? • What are the key development strategies that are implemented by the major players in order to sustain in the competitive market? • Who are the leading players with significant offerings to the Europe hereditary genetic testing market, and what is the expected market dominance for each of these leading players?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
BIS Research社の医療分野での最新刊レポート
本レポートと同じKEY WORD(genetic)の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|